| |
major histocompatibility complex, class II, DR16 | |
Haplotypes groups | DRA*01:DRB1*1601 DRA*01:DRB1*1602 |
Structure (See HLA-DR) | |
Identifiers | alpha *0101 |
Symbol(s) | HLA-DRA [ permanent dead link ] |
EBI-HLA | DRA*0101 |
Identifiers | beta 1 *1601*1602*1604 |
Symbol(s) | HLA-DRB1 [ permanent dead link ] |
EBI-HLA | DRB1*1601 |
EBI-HLA | DRB1*1602 |
EBI-HLA | DRB1*1604 |
Shared data | |
Locus | chr.6 6p21.31 |
HLA-DR16(DR16) is a HLA-DR serotype that recognizes the DRB1*1601, *1602 and *1604 gene products. DR16 is found in the Mediterranean at modest frequencies. DR16 is part of the older HLA-DR2 serotype group which also contains the similar HLA-DR15 antigens.
DRB1* | DR16 | DR2 | DR15 | Sample |
allele | % | % | % | size (N) |
1601 | 41 | 29 | 19 | 703 |
1602 | 47 | 30 | 16 | 239 |
1604 | >50 | 1 | ||
DR16 is associated with Chaga's cardiomyopathy, [2] rheumatic heart disease, [3] coronary artery ectasia, [4] and chronic discoid lupus erythematosus. [5]
DRB1*1601 is associated with tuberculosis risk [6]
DRB1*1602: Juvenile rheumatoid arthritis, [7] rheumatic heart disease, [3] Takayasu arteritis Archived 2007-08-07 at the Wayback Machine , [8] systemic sclerosis (SSc) & anti-DNA topoisomerase I (anti-topo I) antibody, [9] [10] melioidosis (Burkholderia pseudomallei infection) [11]
DRB1*1601:DQA1*0102:DQB1*0502 haplotype is associated with tubeculousis risk [6]
DR16 Haplotypes | |||
Serotypes | DRA | DRB1 | DRB5 |
---|---|---|---|
DR16(2)-DR51 | *0101 | *1601 | *0101 |
*0101 | *1602 | *0101 | |
*0101 | *1604 | *0101 | |
DQA1 | DQB1 | DRB1 | |
DR16(2)-DQ5 (5.2, 1) | *0102 | *0502 | *1601 |
HLA-A | HLA-B | DRB1 | |
A2-B51(5)-DR16(2) | *0201 | *5101 | *1601 |
HLA-DR16 is genetically linked to HLA-DR51 and HLA-DQ5 serotypes.